What was the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to disclose Cencora's entry into a material definitive agreement for a share repurchase and to provide an update on significant share transactions involving Walgreens Boots Alliance Holdings LLC.

How does this share repurchase impact Cencora's financial structure?

The repurchase of approximately $50 million in shares reduces the number of outstanding shares and increases the treasury stock. This can potentially increase earnings per share (EPS) if net income remains constant and signals management's confidence in the company's valuation. The cash used for the repurchase will reduce the company's cash reserves.

What is the significance of Walgreens' remaining ownership and pledged shares?

Walgreens' reduced ownership to approximately 6.5% suggests a significant divestment. However, the fact that their remaining shares are still pledged as collateral for other forward sale contracts indicates that there may be future potential sales or that Walgreens maintains a financial interest tied to these contracts, which could influence future market dynamics.

Are there any immediate financial implications for Cencora from the simultaneous VPF settlements and Rule 144 sale by Walgreens?

While Cencora itself repurchased shares, the VPF settlements and Rule 144 sale by Walgreens are primarily transactions between Walgreens and third-party financial institutions or the market. For Cencora, the immediate impact is the $50 million outflow for the repurchase. The other transactions affect the number of shares outstanding and the ownership structure post-repurchase, but not Cencora's direct financial statements in the same way as the buyback.

COR 8-K: Material Agreements

Summary

Cencora, Inc. (COR) has filed an 8-K detailing a significant share repurchase transaction executed on February 10, 2025. The company repurchased approximately $50 million worth of its common stock, totaling 204,491 shares, directly from Walgreens Boots Alliance Holdings LLC. This transaction was part of Cencora's ongoing share repurchase program and the acquired shares will be held in treasury. The repurchase occurred concurrently with Walgreens Boots Alliance Holdings LLC's settlement of certain variable prepaid forward sale contracts and a Rule 144 sale of 1,081,885 shares. Following these events, Walgreens Boots Alliance Holdings LLC now holds approximately 6.5% of Cencora's outstanding common stock. Investors should note that the remaining shares held by Walgreens are still pledged as security for other outstanding forward sale contracts.

Key Highlights

1Cencora repurchased 204,491 shares of its common stock for approximately $50 million from Walgreens Boots Alliance Holdings LLC.
2The repurchase was executed on February 10, 2025, and was part of the company's existing share repurchase program.
3The repurchased shares will be held in treasury by Cencora.
4The transaction occurred alongside Walgreens' early settlement of variable prepaid forward sale contracts and a Rule 144 sale of over 1 million shares.
5Walgreens Boots Alliance Holdings LLC's ownership stake in Cencora has been reduced to approximately 6.5% of outstanding shares.
6Walgreens' remaining Cencora shares are still pledged as collateral for other forward sale contracts.

Cencora, Inc. 8-K Report, Material Agreement (Feb 10, 2025)

Summary

Key Highlights

Frequently Asked Questions